ACHE and early-onset autosomal dominant Alzheimer disease: Inhibition of Aβ aggregation and its associated oxidative stress, as well as acetylcholinesterase (AChE) activity, is a prospective beneficial approach that can slow or diminish the development of Alzheimer’s disease [112].